Enter your email address below and subscribe to our newsletter

Treatments & Surgery

Share your love

The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 19, a comparative study of the cost and carbon footprint of local anaesthesia techniques for cataract surgery | Eye – Nature

The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 19, a comparative study of the cost and carbon footprint of local anaesthesia techniques for cataract surgery | Eye  Nature Source: Author: | Date: 2024-11-23 08:00:00 Source: Author:…

Innovative VR Solution for Cataract Surgery Training

At the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, Orbis International, together with FundamentalVR, introduced a virtual reality (VR) training tool. This immersive VR solution is especially designed for use in low- and…

Vance Thompson, MD, to Lead ASCRS as New President

The American Society of Cataract and Refractive Surgery (ASCRS) is poised to welcome Vance Thompson, MD, as its new president during the organization’s 2024 annual meeting, which begins this Friday at the Boston Convention and Exhibition Center in Boston. This…

Zeiss Completes Acquisition of DORC

In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…

Qlaris Bio Begins Phase 2 Trials of QLS-111 for Eye Conditions

Qlaris Bio has commenced two critical Phase 2 trials in the United States for its innovative intraocular pressure (IOP)-lowering product, QLS‑111. These masked, randomized clinical trials are designed to investigate the efficacy of QLS‑111 in patients suffering from ocular hypertension…

Melt Pharma Raises $24M for Sedation Tablet

Melt Pharmaceuticals has successfully completed a significant financial milestone, securing approximately $24 million through its Series B Preferred Stock financing round. This latest funding round saw contributions from both new and returning investors, setting the stage for the accelerated development…

Stay informed and not overwhelmed, subscribe now!